Coronavirus

China - Coronavirus News

Coronavirus in China Essentials publishes only the best news and links related to the Covid-19 virus in China, carefully hand-picked and curated by top experts.

Top news of the week: 14.12.2021.

Vaccination
Smallpox
Biotechnology
Vaccine
Monday
Beijing

Coronavirus

@Reuters shared
On Dec 8, 2021
China reports 74 new COVID-19 cases on Dec 7 vs 94 a day earlier https://t.co/1mlz6flyUa https://t.co/5plZ5Ndhmo
Open
China reports 74 new COVID-19 cases on Dec 7 vs 94 a day earlier

China reports 74 new COVID-19 cases on Dec 7 vs 94 a day earlier

China reported 74 new confirmed coronavirus cases for Dec. 7, down from 94 a day earlier, its health authority said on Wednesday.

@Reuters shared
On Dec 11, 2021
China vaccinates over 80% of its people against COVID-19 https://t.co/YDEE89xeeZ https://t.co/UYH6Kn0rsa
Open
China vaccinates over 80% of its people against COVID-19

China vaccinates over 80% of its people against COVID-19

China has vaccinated 82.5% of its population of 1.41 billion against COVID-19, a health official said on Saturday.

@Reuters shared
On Dec 13, 2021
Indonesia to start vaccinating children aged 6-11 against COVID-19 https://t.co/WSL19a2n2f https://t.co/mYqOr2MKpj
Open
Indonesia to start vaccinating children aged 6-11 against COVID-19

Indonesia to start vaccinating children aged 6-11 against COVID-19

Indonesia will start administering COVID-19 vaccinations for children aged between 6-11 on Tuesday, a health ministry official said, as the Southeast Asian country becomes one of the first ...

@Reuters shared
On Dec 8, 2021
Analysis: Omicron is a wake-up call for COVID-19 vaccine developers https://t.co/fxMAkASJrz https://t.co/vDx2UXDQ1z
Open
Analysis: Omicron is a wake-up call for COVID-19 vaccine developers

Analysis: Omicron is a wake-up call for COVID-19 vaccine developers

Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible to the rapid changes of the coronavirus, leading virologists and immunologists told ...

@Reuters shared
On Dec 9, 2021
China approves Brii Biosciences antibody COVID treatment https://t.co/tu9S8GgO7b https://t.co/1Ij8sZXKuC
Open
China approves Brii COVID treatment in adults, teenagers

China approves Brii COVID treatment in adults, teenagers

China's medical products regulator said on Wednesday it had approved the use of Brii Biosciences' neutralising antibody cocktail for COVID-19, the first treatment of its type against the ...

@Reuters shared
On Dec 13, 2021
Antibody response from China Zhifei's COVID shot weaker against Omicron https://t.co/1hPejk39Cd https://t.co/EbMHSdSGqj
Open
Antibody response from China Zhifei's COVID shot weaker against Omicron

Antibody response from China Zhifei's COVID shot weaker against Omicron

China's Anhui Zhifei Longcom Biopharmaceutical said on Monday a small laboratory test showed its COVID-19 vaccine could trigger antibodies against the Omicron variant though the response ...

@Reuters_Health shared
On Dec 13, 2021
China's Brii Biosciences said on Sunday lab studies showed that its COVID-19 antibody cocktail retained activity against the Omicron variant, although one of the antibodies showed a substantial drop in activity when tested alone. https://t.co/VOoIb8KXYV
Open
China's Brii says its COVID-19 antibody cocktail retains activity against Omicron

China's Brii says its COVID-19 antibody cocktail retains activity against Omicron

China's Brii Biosciences said on Sunday lab studies showed that its COVID-19 antibody cocktail retained activity against the Omicron variant, although one of the antibodies showed a ...

@Reuters shared
On Dec 13, 2021
EXCLUSIVE Senegal expects waste of 400,000 COVID-19 vaccines by year-end https://t.co/Vv5DQSD7qW https://t.co/EY8E6ZNci9
Open
EXCLUSIVE Senegal expects waste of 400,000 COVID-19 vaccines by year-end

EXCLUSIVE Senegal expects waste of 400,000 COVID-19 vaccines by year-end

At least 200,000 COVID-19 vaccines have expired in Senegal without being used in the past two months and another 200,000 are set to expire at the end of December because demand is too slow, ...